Evidence map›Paper›PMID 35059977›Full record

ArticleMolecular biotechnology2022

Identification of the Talaromyces cellulolyticus Gene Encoding an Extracellular Enzyme with β-galactosidase Activity and Testing it as a Reporter for Gene Expression Assays.

Alexandra P Orleneva, Vsevolod A Serebrianyi, Ekaterina A Kutukova, Tatiana A Yampolskaya

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexandra P OrlenevaAjinomoto-Genetika Research Institute, 1st Dorozhny proezd, 1-1, Moscow, 117545, Russia.
Vsevolod A SerebrianyiAjinomoto-Genetika Research Institute, 1st Dorozhny proezd, 1-1, Moscow, 117545, Russia. vsevolod_serebrianyi@agri.ru.ORCID http://orcid.org/0000-0001-5077-4176
Ekaterina A KutukovaAjinomoto-Genetika Research Institute, 1st Dorozhny proezd, 1-1, Moscow, 117545, Russia.
Tatiana A YampolskayaAjinomoto-Genetika Research Institute, 1st Dorozhny proezd, 1-1, Moscow, 117545, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The filamentous fungus Talaromyces cellulolyticus (formerly Acremonium cellulolyticus) is currently being intensively studied as a promising industrial producer of a number of secreted cellulolytic enzymes. In this study, the T. cellulolyticus gene lacA, which encodes a protein orthologous to the fungal extracellular β-galactosidases of family 35, was identified. The substitution of the lacA upstream region with a constitutive promoter demonstrated that the product of this gene is effectively secreted and possesses β-galactosidase activity. The optimal pH and temperature values for the hydrolysis of o-nitrophenyl-β-D-galactopyranoside by this enzyme were determined to be pH 4.5-5.5 and 50 °C, respectively. The negligible production of β-galactosidase activity by strains expressing lacA under native regulation raises the possibility of using lacA as a reporter gene. To test this hypothesis, the native promoter of lacA was replaced with the strong inducible promoter of the T. cellulolyticus cellobiohydrolase I gene. The cultivation of the resulting strain in various media showed that the β-galactosidase activity depends on cultivation conditions similar to the cellobiohydrolase activity. Thus, the suitability of lacA as a reporter for evaluating promoters with a wide range of expression profiles was demonstrated.

Indexed as

Talaromycesbeta-GalactosidaseEndo-1,4-beta XylanasesGene Expressionbeta-GalactosidaseEndo-1,4-beta XylanasesKex2 sitePromoter replacementReporter geneTalaromyces cellulolyticusβ-galactosidase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.